Elise Burmeister-Getz

5PUBLICATIONS
8CO-AUTHORS
GlycoconjugatesPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2025
Pharmacokinetics and Safety of Pelacarsen, a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Apo(a), in Participants With Mild Hepatic Impairment.

Jing-He Yan, Amanda J Taylor, Timothy Clough

|Apr 30, 2025
Predicting and Confirming Bioequivalence of Alpelisib Oral Granules and Tablets for Patients With PIK3CA-Related Disorders.

Elise Burmeister Getz, Séverine Niglis, Athanasia Papadimitriou

|Jan 24, 2025
Effect of Target-Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function.

Elise Burmeister Getz, Richard R Stein, Martin Fink

|Aug 19, 2021
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability.

Elise Burmeister Getz, Kevin J Carroll, J David Christopher

|Aug 19, 2021
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.

Elise Burmeister Getz, Kevin J Carroll, Johanna Mielke

Pageof 1

Frequent Collaborators

1 joint publications

Richard R Stein

1 joint publications

Kenneth Kulmatycki

1 joint publications

Eric Lawitz

1 joint publications

Robert Schmouder